Metraipolis › archive › dc_772b35a83afa

Development of nanobody-conjugated LL37 for synergistic therapy against MDR Acinetobacter baumannii — Europe PMC PMID:41649287

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41649287
DOI
10.1128/msphere.00779-25
License (as archived)
solo-consultazione
Archived
2026-11-06T01:55:48.142Z
SHA-256 of the archived text
e6761bea94aa386ec6a0d3254d9aeff731ed708189d922e35344df25b57153fb
Stable URL of this page
https://metraipolis.com/documento/dc_772b35a83afa

How to cite

Development of nanobody-conjugated LL37 for synergistic therapy against MDR Acinetobacter baumannii — Europe PMC PMID:41649287 — Europe PMC (en), https://europepmc.org/article/MED/41649287 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_772b35a83afa (Metraipolis archive dc_772b35a83afa, sha256 e6761bea94aa386ec6a0d3254d9aeff731ed708189d922e35344df25b57153fb)
BibTeX
@misc{dc772b35a83afa,
  title = {Development of nanobody-conjugated LL37 for synergistic therapy against MDR Acinetobacter baumannii — Europe PMC PMID:41649287},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41649287},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_772b35a83afa; sha256 e6761bea94aa386ec6a0d3254d9aeff731ed708189d922e35344df25b57153fb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41649287. Agents can read the archived copy with the MCP tool read_document.